Skip to main content
Advertisement

< Back to Article

Beyond homogeneity: Assessing the validity of the Michaelis–Menten rate law in spatially heterogeneous environments

Fig 3

The sQSSAp, but not the tQSSAp, poses a risk when the enzyme is localized within cells, unlike in an in vitro experiment.

(A) Enzymes localized within cellular organelles. (B) The heterogeneous ICs where the sQSSAo are invalid near x = 15μm (red region) but valid in the other region (blue region). Here S0 ≡ 39 μM, E0(x) = 5 ⋅ f(x)μM, where f(x) is the normalized probability density function of the normal distribution with the mean of 15 μm and the standard deviation of 0.2 μm. (C-D) Unlike the sQSSAp model, the tQSSAp model accurately captures the production of P throughout the domain (C) and its spatial average (D). (E) The ICs in (B) were homogenized so that the validity condition of the sQSSAo is satisfied throughout the domain while maintaining the spatial average concentration. Specifically, S0 ≡ 39 μM and E0 ≡ 5μM were used. (F-G) Both the sQSSAp and tQSSAp models are accurate. (H) Enzyme distributions with varying heterogeneity were constructed using E0(x) = 5 ⋅ f(x|σ) μM, where f(x|σ) is the normalized probability density function of the normal distribution with the mean of 15μm and the standard deviation of σ. As σ decreases, the heterogeneity increases (see Method for details). (I) For the enzyme distribution with varying heterogeneity, the tQSSAp model, but not the sQSSAp model, accurately captures the initial velocity (I). For all simulations, we used kf = 6.7 ⋅ 105M−1s−1, kb = 0.53s−1, kcat = 0.13s−1, KM = 1μM, and the diffusion coefficients: DE = DC = 0μm2/s, and DP = DS = 0.2μm2/s. Some parts of Fig 3 were retrieved from Biorender.

Fig 3

doi: https://doi.org/10.1371/journal.pcbi.1012205.g003